Literature DB >> 10835517

Comparison of the effectiveness of polymerase chain reaction and enzyme immunoassay in detecting Chlamydia trachomatis in different female genitourinary specimens.

E L Chan1, K Brandt, H Stoneham, N Antonishyn, G B Horsman.   

Abstract

BACKGROUND: In high-volume laboratories, enzyme immunoassay (EIA) is the most commonly used method of detecting Chlamydia trachomatis. The optimal specimen for detecting C trachomatis is a combined urethral and cervical swab.
OBJECTIVE: To compare EIA with the combined urethral and cervical swab with polymerase chain reaction (PCR) on urine alone and urine mixed with cervical cells. PATIENTS AND METHODS: Phase 1 of the study included 752 sets of specimens used for comparison. In phase 2, another 212 samples of urine and urine plus cervical cells were added to the study for comparison of the 2 specimen types using PCR.
RESULTS: In phase 1, 648 samples were negative and 76 were positive by all 3 methods and specimen combinations. Enzyme immunoassay was able to detect 81 positive samples (10.8%), whereas PCR on urine alone detected 97 positive samples (12.9%) and PCR on urine plus cervical cells detected 102 positive samples (13.6%), giving a sensitivity of 75%, 93.3%, and 98. 1% respectively. In phase 2, PCR on urine alone detected 119 positive samples (12.3%) and PCR on urine plus cervical cells detected 127 positive samples (13.1%), with a sensitivity of 92.2% and 98.5%, respectively.
CONCLUSION: Polymerase chain reaction on urine alone or urine plus cervical cells is superior to EIA on combined cervical and urethral swabs. There is a slight advantage of adding cervical cells to the urine compared with the urine specimen alone when PCR is used as the assay for detection. The total inhibition rate in our female population is only 3.1% when PCR is used.

Entities:  

Mesh:

Year:  2000        PMID: 10835517     DOI: 10.5858/2000-124-0840-COTEOP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

1.  Comparison of Gen-probe transcription-mediated amplification, Abbott PCR, and Roche PCR assays for detection of wild-type and mutant plasmid strains of Chlamydia trachomatis in Sweden.

Authors:  Jens Kjølseth Møller; Lisbeth Nørum Pedersen; Kenneth Persson
Journal:  J Clin Microbiol       Date:  2008-10-08       Impact factor: 5.948

2.  Should we consider alternatives to combined cervical and urethral swabs for detection of Chlamydia trachomatis in females?

Authors:  M Mahto; H Mallinson
Journal:  Sex Transm Infect       Date:  2007-07-04       Impact factor: 3.519

3.  Analysis of laboratory testing results collected in an enhanced chlamydia surveillance system in Australia, 2008-2010.

Authors:  Wayne Dimech; Megan S C Lim; Caroline Van Gemert; Rebecca Guy; Douglas Boyle; Basil Donovan; Margaret Hellard
Journal:  BMC Infect Dis       Date:  2014-06-12       Impact factor: 3.090

4.  Comparison of clinical performance of antigen based-enzyme immunoassay (EIA) and major outer membrane protein (MOMP)-PCR for detection of genital Chlamydia trachomatis infection.

Authors:  Mahmoud Nateghi Rostami; Batool Hossein Rashidi; Fatemeh Aghsaghloo; Razieh Nazari
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.